Everolimus Tablet, For Suspension
Product Images NDC 60219-2279

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 60219-2279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 1)

FDA Label Image

09 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 10)

FDA Label Image

10 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 11)

FDA Label Image

11 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 12)

FDA Label Image

12 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 13)

FDA Label Image

13 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 14)

FDA Label Image

14 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 15)

FDA Label Image

15 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 16)

FDA Label Image

16 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 17)

FDA Label Image

17 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 18)

FDA Label Image

18 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 19)

FDA Label Image

01 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 2)

FDA Label Image

19 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 20)

FDA Label Image

20 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 21)

FDA Label Image

21 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 22)

FDA Label Image

22 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 23)

FDA Label Image

23 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 24)

FDA Label Image

4 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 25)

FDA Label Image

25 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 26)

FDA Label Image

26 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 27)

FDA Label Image

27 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 28)

FDA Label Image

28 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 29)

FDA Label Image

02 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 3)

FDA Label Image

29 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 30)

FDA Label Image

30 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 31)

FDA Label Image

31 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 32)

FDA Label Image

1 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 33)

This text contains information about Everolimus tablets for oral suspension, including storage conditions (20°C to 25°C), protection from light and moisture, manufacturer details (Amneal Pharmaceuticals), and expiration date (10.2024). The tablets are made in India and the packaging includes various serial and lot numbers.*

FDA Label Image

004 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 34)

This is a description for Everolimus Tablets for Oral Suspension containing 28 tablets for dispersing in water. Each tablet contains 2 mg of everolimus, USP. It is important not to swallow, chew, or crush the tablets whole. The product is for oral use only, and dosage information can be found in the package insert. The product should be stored at temperatures between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The original container should be used for storage, protecting it from light and moisture. Instructions for use are enclosed. For more information, visit amneal.com or call 1-877-835-5472.*

FDA Label Image

2 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 35)

This text provides details regarding Everolimus Tablet for Oral Suspension, including storage instructions and manufacturer information. It specifies storing the tablets at a temperature range of 20°C to 25°C, protecting them from light and moisture. The manufacturer mentioned is Amneal Pharmaceuticals. The text also contains multiple NDC numbers associated with the product.*

FDA Label Image

005 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 36)

This text contains information about Everolimus tablets for oral suspension. Each tablet contains 3 mg of everolimus. The tablets must be dispersed in water and not swallowed whole, chewed, or crushed. Additionally, the text provides details on how to store the tablets and where to find more information. For further details, visit www.amneal.com or call 1-877-835-5472.*

FDA Label Image

3 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 37)

This text seems to be a series of product labels for Everolimus Tablets for Oral Suspension by Amneal Pharmaceuticals. The text provides information on storage instructions, expiration dates, manufacturing details, and emphasizes that the product should be stored in its original container away from light and moisture. It appears to be a pharmaceutical product label.*

FDA Label Image

006 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 38)

This is a description of a medication named Everolimus Tablets for Oral Suspension, with each tablet containing 5 mg of everolimus, USP. The medication comes in a carton with 28 tablets for oral suspension, divided into 4 individual blister cards of 7 tablets. It is important to note that the tablets must be dispersed in water and should not be swallowed whole, chewed, or crushed. The storage instructions include keeping the tablets at 20° to 25°C (68° to 77°F) and protecting them from light and moisture. For more information, you can visit www.amneal.com or call 1-877-835-5472.*

FDA Label Image

03 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 4)

FDA Label Image

04 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 5)

FDA Label Image

3 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 6)

FDA Label Image

06 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 7)

FDA Label Image

07 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 8)

FDA Label Image

08 (Everolimus Tablets For Oral Suspension 2 mg 3 mg A 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.